HEALTH TIPS.: Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Friday, 29 January 2021

Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

submitted by /u/Fitness_and_Finance
[link] [comments]

from Health https://ift.tt/2MjjCRM
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)